Recent studies demonstrate that KCNMA1 is amplified in several malignant diseases, including prostate cancer, breast cancer, ovarian and endometrium carcinoma, and contributes to high proliferation rate and malignancy [15,16]. Here, KCNMA1 is linked to breast carcinoma.